SL

Saroj Lalit Talati

Active Director Director DIN 00201384
DIN 00201384 First appointment Feb 1985 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 1985
Shareholding value •••• Premium profile

About Saroj Lalit Talati

Data last updated:

Saroj Lalit Talati is a Director at Nemi Pharma Pvt Ltd (since 1985). The company operates in Financial Services. Nemi Pharma Pvt Ltd reported revenue of ₹30.7 Lakh (FY 2025).

DIN 00201384
Primary Designation Director
Industry Financial Services
First Appointment 06 Feb 1985
Oldest Company Age 41 yrs
Largest company Nemi Pharma Pvt Ltd · ₹30.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nemi Pharma Pvt Ltd U24230MH1985PTC035276
Director06 Feb 19851985₹30.7 Lakh (FY 2025)Active

Board colleagues of Saroj Lalit Talati

NameDINCompanyDesignation
Lalit Surendra Talati00201299Nemi Pharma Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Nemi Pharma Pvt Ltd
Premium access

Shareholding and investment profile for Saroj Lalit Talati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saroj Lalit Talati

Saroj Lalit Talati currently holds 1 directorship: Nemi Pharma Pvt Ltd (Director, since 06 Feb 1985, revenue ₹30.7 Lakh (FY 2025)).

Saroj Lalit Talati was first appointed on 06 Feb 1985 as Director at Nemi Pharma Pvt Ltd.

The current boards of Saroj Lalit Talati's companies include Lalit Surendra Talati (Nemi Pharma Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available